Afleveringen
-
People often ask me, āWhatās the difference between Thymosin Beta-4 and TB-500?āāand itās a great question! These two peptides might seem the same, but they do have some important differences.
In this podcast, weāll discuss the key differences between the two.
1. Origin and StructureThymosin Beta-4 (TĪ²4) is a naturally occurring peptide in the body, found in high concentrations in tissues like blood, wound fluids, and muscles. It plays a crucial role in cell migration, wound healing, and reducing inflammation. TĪ²4 is a full-length peptide composed of 43 amino acids.
TB-500 is a synthetic version of a smaller, more active segment of Thymosin Beta-4. Itās designed to mimic the regenerative properties of TĪ²4 while being more stable and easier to produce for therapeutic purposes. TB-500 typically consists of a shorter sequence of TĪ²4, around 17 amino acids, the active region responsible for much of the healing and recovery benefits.
2. Purpose and UseThymosin Beta-4 is used in research and experimental medicine to understand its broad biological functions. It is involved in promoting tissue repair, cell growth, and regeneration on a cellular level.
TB-500 is primarily used as a therapeutic peptide for muscle recovery, wound healing, and reducing inflammation. It is often chosen because it is more cost-effective and easier to synthesize than the longer TĪ²4 peptide.
3. Effects on the BodyThymosin Beta-4 has a wide range of biological effects, including promoting angiogenesis (forming new blood vessels), reducing inflammation, and supporting the migration of cells to injury sites. It also helps prevent fibrosis (scarring) and promotes hair growth and stem cell differentiation.
TB-500 focuses more on specific healing and recovery functions. It has been shown to improve muscle recovery, speed up the healing of tendons and ligaments, and reduce inflammation, making it popular among athletes for injury recovery. However, TB-500 does not have all the broader effects that the full-length Thymosin Beta-4 peptide has.
4. AvailabilityThymosin Beta-4 is less commonly available in the market due to its complexity and cost of production.
TB-500 is more widely available as a synthetic peptide and is commonly used in therapeutic and athletic settings due to its relative affordability and ease of use.
Itās important to be aware that some suppliers use the names TB-500 and Thymosin Beta-4 interchangeably, making it tricky to know exactly what you're buying. To ensure you're getting peptides from a reputable source, look for peptide clinics that use trusted compounding pharmacies that provide lab testing and certificates of analysis for each batch. Reputable pharmacies will also have clear product descriptions and will be transparent about sourcing, quality control, and regulatory compliance.
5. AdministrationBoth Thymosin Beta-4 and TB-500 are usually administered via subcutaneous or intramuscular injections. However, due to the synthetic nature and shorter sequence of TB-500, it is typically more stable and easier to store and handle than the full-length TĪ²4.
The doses vary depending on the condition being treated, with higher doses typically used for more severe injuries or recovery needs, while maintenance doses are lower for ongoing healing or injury prevention.
In summary, TB-500 provides a more practical approach to healing and recovery, while Thymosin Beta-4 offers a wider range of biological benefits but is less commonly used outside of research settings.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
If youāre ready to dive deeper into the world of nutrition, donāt miss my new ebook, Eat Smart: Powerful Tips for a Healthier You, now available on Amazon! Itās packed with easy-to-understand, science-backed tips to help you optimize your diet, boost metabolism, and reduce inflammation. The best part? If you have Kindle Unlimited, itās always free! So grab your copy today and start your journey to a healthier, smarter way of eating!
-
Imagine a treatment that not only helps manage diabetes but also holds the potential to reverse kidney failure ā what was once thought to be impossible. The recent FLOW study has remarkable groundbreaking evidence that GLP-1 receptor agonists can significantly improve kidney function in chronic kidney disease (CKD) patients. And while researchers try to understand the full implications of these findings, one thing is clear: the landscape of kidney disease treatment may never be the same again.
In this podcast, weāll dive into the results of the FLOW trial and explore what they may mean for people at risk for kidney failure.
What are GLP-1 Agonists?GLP-1 (glucagon-like peptide-1) agonists are a class of drugs that mimic the effects of the natural hormone GLP-1. They enhance insulin secretion, inhibit glucagon release, and slow gastric emptying, improving blood sugar control. Beyond their primary use in diabetes management, GLP-1 agonists have been studied for various conditions, including obesity and cardiovascular disease prevention.
The Study OverviewThe FLOW trial, which stands for "Fasting and Long-acting GLP-1 Receptor Agonist in Patients with Chronic Kidney Disease," focused on the impact of GLP-1 receptor agonists, specifically semaglutide, on patients with chronic kidney disease (CKD) and type 2 diabetes (those most at risk for kidney failure).
Researchers observed a remarkable trend: patients receiving semaglutide demonstrated stabilization of kidney function and signs of renal recovery. This was groundbreaking, as reversing kidney damage has long been considered a near-impossible feat.
Study ObjectivesThe primary goal was to determine whether treatment with GLP-1 receptor agonists could improve kidney outcomes in patients with CKD.
Study DesignParticipants: The study enrolled >3500 adults with type 2 diabetes and CKD.
Intervention: Participants were randomized to receive either semaglutide or a placebo.
Primary Outcomes: The main outcomes included changes in glomerular filtration rate (GFR) and the incidence of major adverse kidney events (kidney failure- need for transplantation or dialysis).
Key FindingsRenal Function Improvement: Patients on semaglutide showed significant improvements in glomerular filtration rates (GFR), a key indicator of kidney function.
Reduced Inflammation: The drugs appeared to lower levels of inflammatory markers associated with kidney damage, suggesting a protective effect.
Metabolic Benefits: Improvements in blood sugar control and weight loss were also observed, contributing to overall health and potentially alleviating stress on the kidneys.
Adverse Events: The treatment was generally well-tolerated, with a favorable safety profile.
Ethical ConsiderationsAs the results began to emerge, the ethical landscape of the study shifted dramatically. The control group, which was not receiving semaglutide, was found to be at a significantly higher risk of kidney deterioration. With compelling evidence that the GLP-1 agonist was safe and potentially life-saving, the ethics committee determined withholding treatment from any participants was no longer justifiable.
Consequently, the study was halted prematurely to allow all participants access to the medication, prioritizing patient welfare over the continuation of research under an inequitable framework. This decision underscores the ethical responsibility of researchers to ensure that all patients receive the best possible care, especially when clear benefits are identified.
Implications for Future ResearchWhile the early termination of the study raises questions about the completeness of the data collected, it also opens new avenues for further research. The findings encourage more extensive clinical trials to explore the mechanisms behind the renal protective effects of GLP-1 agonists. Additionally, there is a growing interest in investigating these drugs' long-term effects on kidney health and their potential role in preventing disease progression.
As further studies unfold, there is hope that GLP-1 agonists will become a standard part of kidney disease management, potentially transforming outcomes for millions affected by this condition.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Zijn er afleveringen die ontbreken?
-
Have you heard of fatty liver disease? Well, fatty liver disease is just what it sounds likeāit's when fat builds up in the liver and starts causing issues. The official name for it is ānonalcoholic fatty liver disease,ā or NAFLD for short. Now, if that fat buildup leads to inflammation, itās called ānonalcoholic steatohepatitis,ā or NASH. The ānonalcoholicā part just means itās not caused by alcohol, which can also lead to similar liver problems. NASH is a more severe liver disease compared to NAFLD. This is because inflammation in the liver can lead to cirrhosis (scarring or fibrosis of the liver) and liver failure.
Fatty liver disease happens when there's too much fat in the liver, but weāre still figuring out what actually causes that buildup. We do know that carrying extra body fat can raise the risk, and how our bodies handle sugars and fats might play a role, too. Itās also more common in Hispanic people than in other racial groups. Additional risk factors include a larger waist size, type 2 diabetes, and metabolic syndrome.
Most people with fatty liver disease donāt have any symptoms. These happen much later in people who have more severe liver disease. If and when symptoms do happen, some people experience jaundice (yellowing of the skin or eyes), fatigue, and abdominal swelling from fluid build-up (ascites). Weakness, weight loss, and nausea or vomiting can also occur.
People usually find out they have fatty liver disease by chance, often during tests for something else. For instance, routine blood tests might reveal higher levels of liver enzymes like AST and ALT.
The increasing prevalence of obesity and metabolic syndrome has made NASH a significant public health concern. However, recent research has highlighted glucagon-like peptide-1 (GLP-1) agonists as a promising therapeutic option for improving NASH.
In this podcast, weāll discuss how GLP-1 agonists work and the clinical evidence supporting their effectiveness in treating NASH.
Understanding GLP-1 AgonistsGLP-1 is an incretin hormone produced in the intestines that plays an important role in glucose metabolism. GLP-1 agonists, such as liraglutide and semaglutide, mimic the action of this hormone, leading to increased insulin secretion, decreased glucagon release, and reduced appetite. Originally developed for the treatment of type 2 diabetes, GLP-1 agonists have gained attention for their potential effects on liver health, particularly in NASH patients.
How Do GLP-1 Agonists Work in NASH?Weight Loss and Appetite Regulation: One of the primary benefits of GLP-1 agonists is their ability to promote weight loss. Excess weight is a significant risk factor for NASH, and weight reduction can lead to improvements in liver histology and function. By decreasing appetite and increasing satiety, these medications can help patients achieve significant weight loss, which may directly improve liver health.
Improved Insulin Sensitivity: GLP-1 agonists enhance insulin sensitivity and glucose metabolism. Improved insulin action can reduce hepatic fat accumulation, a key feature of NASH. These agents may help manage the underlying metabolic dysregulation associated with NASH by improving insulin resistance.
Direct Liver Effects: Emerging evidence suggests that GLP-1 receptors exist in liver cells. Activation of these receptors may directly influence liver inflammation and fibrosis. GLP-1 agonists have been shown to reduce markers of liver inflammation and fibrosis in preclinical models, indicating a potential role in mitigating liver damage.
Antioxidant Properties: GLP-1 has antioxidant effects, which can help reduce oxidative stressāa significant contributor to liver injury in NASH. By decreasing oxidative stress, GLP-1 agonists may protect liver cells from damage and promote better liver health.
Clinical Study FindingsSeveral clinical studies have explored the efficacy of GLP-1 agonists in treating NASH, with promising results:
Liraglutide Study: In a randomized controlled trial, patients with NASH treated with liraglutide showed significant reductions in liver fat content and improved liver histology after 48 weeks. The study reported a reduction in necroinflammation and fibrosis scores, highlighting the potential of liraglutide as a therapeutic agent for NASH.
Semaglutide Research: A recent trial involving semaglutide demonstrated notable improvements in liver fat content and metabolic parameters among participants with NASH. The study indicated that patients experienced a significant reduction in body weight, which correlated with improved liver function tests and reduced hepatic inflammation.
Long-Term Benefits: Ongoing research examines the long-term effects of GLP-1 agonists on NASH progression and resolution. Early data suggest that sustained treatment can lead to lasting improvements in liver health, reinforcing the need for long-term management strategies in patients with NASH.
GLP-1 agonists look like real game-changers when treating NASH. They help with weight loss, boost insulin sensitivity, and even offer direct protection to the liver. Clinical studies back this up, showing that these medications can improve liver health and tackle the metabolic issues tied to NASH. As research continues, GLP-1 agonists might become a key part of managing this condition, bringing new hope to those dealing with this growing liver disease.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Someone might switch from semaglutide to tirzepatide to achieve greater weight loss or improve blood sugar control. Tirzepatide has been shown to be more effective for some people because it works on two different hormones, GLP-1 and GIP. This combination can lead to better results in managing weight and overall health.
Additionally, if a person stops losing weight on semaglutide or isn't feeling as much appetite suppression, switching to tirzepatide could provide a new option, especially at higher doses.
In this podcast, weāll discuss the feedback from doctors and patients about switching from semaglutide to tirzepatide for weight loss. The experiences shared are quite varied. Here are some common themes based on what healthcare providers and patients reported.
1. Appetite SuppressionPatients' Experiences:
Some patients report weaker appetite suppression with tirzepatide compared to semaglutide. They mention that they felt more consistently full or experienced less "food noise" (persistent thoughts about food) with semaglutide.
Others find tirzepatide equally or more effective at reducing hunger, especially at higher doses (10 mg to 15 mg). They note that their appetite was well-controlled after titrating to these higher doses.
Clinicians' Observations:
Many clinicians observe that tirzepatideās appetite suppression is dose-dependent, with lower doses (5 mg) sometimes being less effective than semaglutide 2.4 mg, but higher doses (7.5 mg and up) providing stronger suppression.
Some clinics report that patients may need more time on tirzepatide for the full appetite-suppressing effects to become noticeable.
2. Weight Loss:Patients' Experiences:
Many patients experience greater or more rapid weight loss with tirzepatide, especially when titrated to higher doses (10 mg or more). Some report that they plateaued with semaglutide but started losing more weight after switching to tirzepatide.
Others find that their weight loss slows down after switching to tirzepatide, particularly if their tirzepatide dose starts low (e.g., 2.5 or 5 mg), which may take time to match the effects of semaglutide 2.4 mg.
Clinicians' Observations:
Physicians often report that tirzepatide tends to lead to greater weight loss overall compared to semaglutide, especially when patients reach the higher doses (15 mg).
However, individual variability plays a significant role, with some patients responding better to one medication over the other, depending on their metabolic profile and personal response to the medications.
3. Side Effects:Patients' Experiences:
Patients commonly note that tirzepatide's side effects are similar to semaglutide, particularly stomach-related symptoms like nausea, vomiting, and diarrhea. However, these effects tend to lessen over time with both medications.
On the other hand, some patients may experience more intense side effects with tirzepatide, especially during the titration phase.
Clinicians' Observations:
Clinics generally find that tirzepatideās tolerability improves when the dose is titrated slowly, starting at 2.5 mg. Jumping directly to higher doses (5 mg or more) can increase the likelihood of nausea and other stomach-related side effects.
Long-term side effect profiles are comparable between the two, but some clinics observe that tirzepatide's dual mechanism (GIP + GLP-1) might cause more initial stomach discomfort in certain patients.
4. Patient Preferences:Some patients prefer staying on semaglutide because it effectively curbs their hunger and controls cravings better, even if tirzepatide provides more weight loss.
Others favor tirzepatide due to its better results in weight loss and overall improvements in metabolic health, especially once they reach higher doses.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Imagine waking up refreshed after a full nightās sleep, free from the constant interruptions of obstructive sleep apnea (OSA). Now, imagine treating your OSA without relying on a bulky CPAP machine but with a convenient once-weekly injectable medication instead. Enter tirzepatide, the breakthrough peptide originally designed for diabetes and weight loss, is now making waves in treating OSA.
Recent studies reveal that tirzepatide (Mounjaro, Zepbound) reduces apnea episodes and promotes significant weight loss, tackling one of the root causes of sleep apnea.
In this podcast, weāll talk about the science behind this exciting new study.
Tirzepatide is a dual agonist that acts like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). GLP-1 and GIP are hormones naturally produced in the gut.
These hormones are important in regulating blood sugar levels, insulin secretion, and appetite control, which is why tirzepatide was first developed for type 2 diabetes and obesity management. By mimicking these hormones, tirzepatide enhances insulin sensitivity, reduces glucagon levels, and slows gastric emptying, which collectively aids in appetite suppression and promotes significant weight loss.
The connection between tirzepatide and obstructive sleep apnea (OSA) lies in its ability to reduce body weight. OSA is often exacerbated by excess fat around the neck and airway, which leads to airway obstruction during sleep.
Weight loss is one of the most effective non-surgical treatments for OSA because it reduces this physical pressure, allowing the airway to stay open during sleep. By helping patients lose a substantial amount of weight, tirzepatide can reduce the severity of OSA symptoms.
The latest publication from the New England Journal of Medicine (NEJM) discusses the impact of tirzepatide on obstructive sleep apnea (OSA) in individuals with obesity.
Tirzepatide was tested in the SURMOUNT-OSA trial to determine its effect on OSA. The study showed that tirzepatide significantly reduced the severity of OSA over one year. The primary measurement was the Apnea-Hypopnea Index (AHI), which tracks the number of breathing interruptions per hour during sleep.
In the trials, participants experienced a reduction in AHI by up to 56% compared to placebo. Additionally, body weight decreased by 16-17%, which is notable since weight loss directly improves OSA symptoms.
Beyond the improvements in sleep quality, the study also observed benefits like reduced blood pressure, which could have positive cardiovascular implications for patients with OSA. But, further research is needed to determine whether these improvements lead to long-term reductions in cardiovascular events.
Tirzepatideās effectiveness in treating OSA provides a promising new avenue for managing the condition, especially for patients who struggle with conventional therapies like CPAP or want to avoid oral facial surgery.
The full clinical impact of tirzepatide on patient-centered outcomes, such as quality of life and long-term health benefits, is still under investigation. While initial studies show promising improvements in sleep apnea severity and weight loss, more research is needed to fully understand its effects on broader health markers and long-term outcomes.
Additional trials will determine whether these short-term benefits translate into sustained improvements in overall health, quality of life, and reduced risks of associated conditions such as cardiovascular diseaseā.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Curious about how tirzepatide can help with weight loss? From understanding how it works to managing potential side effects, many have questions about this medication.
In this podcast, weāll discuss the top questions to give you a clearer picture of how tirzepatide might fit into your weight loss journey.
How does tirzepatide work for weight loss?Tirzepatide, marketed as Zepbound, mimics the action of GLP-1 and GIP, two hormones naturally released by your gut. These hormones are critical in regulating appetite and how much food you consume. By enhancing the feeling of fullness and reducing hunger, tirzepatide helps support weight loss. Specifically, it has the following effects:
Slows stomach emptying, helping you feel full longer after meals.
Decreases appetite, leading to reduced food intake.
Reduces food cravings.
Stimulates the pancreas to release more insulin, which lowers blood sugar levels.
Reduces the liverās new glucose production, further improving blood sugar control.
These combined effects make tirzepatide a powerful tool for weight management and improving metabolic health.
1. How long does it take for tirzepatide to work?
In clinical trials, people typically began to notice weight loss around 4 weeks after starting tirzepatide. This is when the medication reaches stable levels in the body. The trial lasted for 72 weeks, and the participants continued to lose weight throughout the study. However, the most significant results were observed during the first 8 to 9 months of treatment.
2. How much weight do people lose with tirzepatide?
Tirzepatide is one of the most effective weight-loss treatments available. In clinical trials, people lost, on average, between 15% and 21% of their starting body weight after 72 weeks of treatment.
Additionally, longer treatment with tirzepatide tends to lead to more significant weight loss. People in two different studies lost an average of 25% of their starting body weight when using tirzepatide for an extended period.
3. Whatās the typical tirzepatide dosage for weight loss?
The initial tirzepatide dosage is 2.5 mg once a week for the first 4 weeks. After that, the dose is increased to 5 mg weekly. Most people remain on the 5 mg dose for the long term. If necessary, the dose can be gradually increased. But the increases should be by no more than 2.5 mg at a time, and there should be at least 4 weeks in between each one. The maximum tirzepatide dose is 15mg weekly.
4. How long does tirzepatide stay in your system?
Tirzepatide has a half-life of about 5 days, meaning that it takes this amount of time for your body to eliminate half of the medication. This helps determine when a medication starts wearing off and influences its dosing schedule. Since Tirzepatideās half-life is 5 days, it only needs to be injected once weekly.
On the other hand, a longer half-life means it takes more time for your body to fully eliminate a medication. In the case of tirzepatide, small amounts of the medication may remain in your system for up to 25 days after a dose.
5. How long do you need to take tirzepatide?
The duration of tirzepatide treatment depends on your health and weight loss goals. Itās best to work with your healthcare provider to determine a timeline that suits your needs. Keep in mind that tirzepatide is designed for long-term use. Still, it may only be needed temporarily if you're able to adopt and sustain certain lifestyle changes after discontinuing the medication .
Research shows that maintaining weight loss with tirzepatide is achievable with continued use. At the end of clinical trials, nearly 90% of participants maintained at least 80% of the weight they lost during the first 8 to 9 months.
If you plan to stop taking tirzepatide, itās important to work with your healthcare provider to develop a strategy to help maintain your weight loss. They can help create a plan to continue important lifestyle changes such as proper nutrition, regular physical activity, stress management, and quality sleep.
6. Can you change your tirzepatide injection day?
Yes, you can adjust your tirzepatide injection day if needed (e.g., illness, vacation, side effects), but there are specific guidelines to follow.
When switching injection days, make sure thereās at least a 3-day (72-hour) gap between two doses. For instance, if you typically inject on Saturdays, you could move it to Tuesday (or another later day in the same week).
It's important to consult your healthcare provider before making this change. They can give you a safe and appropriate schedule based on your circumstances.
7. Can you switch from semaglutide to tirzepatide?
Yes, you can switch from semaglutide to tirzepatide if you need additional support with weight management.
Based on your current semaglutide dosage and any side effects you're experiencing, your healthcare provider may begin you on a lower dose of tirzepatide. This approach allows your body to adjust to tirzepatide and helps determine your optimal dose.
Itās important to note that some individuals transitioning from semaglutide to tirzepatide report that semaglutide remains more effective in various aspects, including appetite suppression, managing food cravings, and achieving weight loss goals.
They often note that semaglutide helps reduce "food noise," or the persistent thoughts about food, more effectively than tirzepatide.
This variation in response highlights the individual nature of weight management medications, suggesting that while tirzepatide may work well for many, semaglutide may better address specific needs for others, particularly in controlling cravings and enhancing overall satiety.
8. What are the most common side effects of Tirzepatide?
The most frequently reported side effects are nausea and constipation. Less commonly, you might experience other gastrointestinal issues such as indigestion, vomiting, diarrhea, burping, and flatulence. Some people have also reported headache and fatigue.
9. How do I manage constipation on tirzepatide?
Drink plenty of fluids to stay hydrated and help prevent constipation. To estimate your daily water intake, take your weight in pounds and divide it by two. This will give you the approximate number of ounces of water you should drink each day. For instance, if you weigh 200 pounds, you should aim for about 100 ounces (or 3 liters) of water daily. This amounts to roughly five 20-ounce bottles of water each day. You should drink more if you live in warmer, humid climates or work outside.
Engage in exercise 3-4 times a week to support regular bowel movements. This can be as simple as walking 10 to 15 minutes after each meal.
Get more fiber. If youāre a woman, you should consume 25 grams of dietary fiber each day to prevent constipation. You should consume 38 grams of dietary fiber each day if you're a man. Try eating more whole grains, fruits, and vegetables to get more fiber. Beans, nuts, and seeds are also a great source of dietary fiber. Remember that consuming too much fiber is possible, particularly if you increase your intake suddenly. Excessive fiber can cause bloating, gas, and constipation. To avoid these issues, gradually introduce more fiber into your diet.
Consider using Metamucil or a stool softener such as docusate sodium if necessary. But always check with your healthcare provider first. They can make sure itās safe for you to take.
10. How do I manage nausea on tirzepatide?
Staying hydrated and eating small meals may help. Try to avoid spicy, greasy, or fried food. These foods can irritate the stomach lining and make nausea worse. If nausea persists or becomes severe, consulting with your healthcare provider is important, as they may recommend anti-nausea medications or adjust your tirzepatide dose.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
What is SS-31? Ela-mep-ra-tide
SS-31, also known as Elamipretide, is a synthetic peptide that has gained attention in the scientific and medical communities for its potential role in treating various age-related and degenerative diseases. It is a small, mitochondria-targeting peptide specifically designed to protect and improve the function of mitochondria, the energy-producing "powerhouses" of our cells.
Since mitochondrial dysfunction is linked to many chronic illnesses and the aging process, SS-31 has sparked interest in its potential to restore cellular energy and combat diseases at the cellular level.
In this podcast, weāll discuss how SS-31 works and its potential benefits.
How Does SS-31 Work?
Mitochondria are essential for producing energy in cells through a process known as oxidative phosphorylation. During this process, mitochondria generate ATP, the primary energy source for most cellular functions. However, as we age or develop certain diseases, mitochondria can become less efficient, leading to oxidative stress and damage to cellular structures. This damage can result in various health issues, from muscle weakness to neurodegenerative diseases.
SS-31 directly interacts with cardiolipin, a key phospholipid in the inner mitochondrial membrane. Cardiolipin plays an essential role in maintaining mitochondrial structure and function. When mitochondria are stressed or damaged, cardiolipin can become dysfunctional. SS-31 binds to cardiolipin and helps stabilize it, protecting mitochondria from further damage. This stabilization improves mitochondrial efficiency, reduces oxidative stress, and enhances energy production.
Additionally, SS-31 helps reduce the production of reactive oxygen species (ROS), harmful molecules that can contribute to inflammation and cellular damage. By reducing oxidative stress, SS-31 may help prevent further damage to tissues and cells, slowing the progression of disease and the aging process.
Potential Benefits of SS-31
Research on SS-31 is still in the early stages, but some potential benefits of this peptide have been identified, particularly in the context of mitochondrial health and age-related diseases.
1. Improved Muscle Function
SS-31 has been shown to enhance muscle function, particularly in older adults or those with muscle-related diseases. By improving mitochondrial efficiency, SS-31 may help increase muscle strength and endurance, potentially benefiting conditions like sarcopenia (age-related muscle loss) and muscular dystrophies.
2. Neuroprotection
Since mitochondrial dysfunction is linked to neurodegenerative diseases such as Alzheimer's and Parkinson's, SS-31ās ability to stabilize mitochondria may offer neuroprotective effects. Early research suggests that SS-31 may help protect brain cells from oxidative damage and reduce inflammation, which could slow the progression of neurodegenerative diseases.
3. Cardiovascular Health
SS-31 may also have potential benefits for heart health. By protecting mitochondria in cardiac cells, SS-31 could help prevent damage to the heart and improve its function. Some studies have explored its role in treating conditions like heart failure and ischemia-reperfusion injury, where mitochondrial dysfunction plays a significant role.
4. Anti-Aging Properties
Because mitochondrial damage is closely associated with aging, SS-31 may have anti-aging benefits. By improving mitochondrial function and reducing oxidative stress, SS-31 could help slow the aging process at the cellular level, promoting healthier aging and potentially extending lifespan.
5. Treatment of Metabolic Disorders
There is growing interest in SS-31ās potential to treat metabolic disorders such as diabetes. Mitochondrial dysfunction is linked to insulin resistance, and improving mitochondrial function with SS-31 could enhance glucose metabolism and insulin sensitivity.
6. Increased energy levels
SS-31 peptide boosts energy by targeting and protecting mitochondria, the "powerhouses" of your cells. Mitochondria generate ATP, the main energy source for cellular functions.
As we age or experience stress, mitochondrial efficiency declines, leading to fatigue and reduced cellular energy. SS-31 works by stabilizing the mitochondria, preventing oxidative damage, and improving ATP production. This results in increased cellular efficiency, allowing you to feel more energized. It's like upgrading an old car engineāit runs smoother, more efficiently, and with less strain, giving you more stamina throughout the day.
What to listen to next:
To learn more about how other peptides can help with neurodegenerative diseases, listen to our podcast discussing the potential use of GLP-1 agonists in Alzheimerās disease and how they work or DIHEXA and cognitive health.
To learn more about how other peptides can help heart health, listen to our podcast about GLP-1 agonists in the context of post-MI management.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Two of the most promising treatments for obesity in recent years are semaglutide, a GLP-1 agonist, and tirzepatide, a dual GLP-1/GIP agonist. These peptides have garnered attention for their impressive efficacy in weight loss and metabolic improvement, but they differ in their mechanisms, dosing, side effects, and outcomes. In this podcast, we'll explore how these peptides compare.
Semaglutide and tirzepatide work in similar but slightly different ways for weight lossSemaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that is naturally released by the gut in response to food. GLP-1 helps regulate appetite by increasing the feeling of fullness (satiety), slowing gastric emptying, and reducing the body's insulin resistance. It also stimulates insulin secretion, which helps control blood sugar levels, making it useful not only for weight loss but also for managing type 2 diabetes.
Tirzepatide activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. GIP is another hormone involved in insulin secretion, but it also plays a role in fat metabolism. By engaging both receptors, tirzepatide has a dual/additive impact: it not only boosts insulin sensitivity and appetite suppression (similar to semaglutide) but also enhances the body's ability to process fat and use it for energy ā providing an added benefit for weight loss and metabolic health.
Tirzepatide may result in greater weight loss compared with semaglutideSemaglutide has been shown to reduce body weight by 10-15% in most clinical trials, with some patients achieving even greater weight loss (up to 17% of total body weight). Additionally, it has proven effective in reducing blood glucose levels and improving insulin sensitivity, making it a great option for patients with type 2 diabetes and obesity.
Tirzepatide has shown superior weight loss efficacy, with reductions of up to 20-25% of body weight in clinical trials. Its dual action on GLP-1 and GIP receptors may explain this enhanced efficacy. It also offers significant improvements in metabolic markers, including better glucose control and insulin sensitivity, which can especially benefit patients with obesity-related metabolic disorders (e.g., type 2 diabetes and polycystic ovary syndrome)
Semaglutide and tirzepatide have different dosesSemaglutide is typically administered as a once-weekly injection. The dosing for weight loss starts at 0.25 mg per week and gradually increases in 4-week intervals to a maintenance dose of 2.4 mg per week. The gradual titration helps minimize side effects such as nausea. Sometimes, the semaglutide dose may be increased sooner than the 4-week interval based on the personās response to the peptide.
Tirzepatide is also administered as a once-weekly injection. The dosing for weight loss starts at 2.5 mg per week and gradually increases to a maintenance dose of 5 mg to 7.5 mg per week, with some people requiring higher doses (10 mg, 12.5 mg, or 15 mg). The dose is generally increased based on patient tolerance, similar to semaglutide but shouldnāt be increased sooner than 4 weeks.
Semaglutide and tirzepatide have similar side effectsCommon side effects of semaglutide include:
Nausea
Vomiting
Diarrhea
Constipation
Headache
Tiredness
These stomach-related side effects are usually temporary and go away on their own as the body adjusts to the medication. However, some people may experience more severe symptoms, necessitating a lower dose.
Tirzepatide shares many of the same side effects as semaglutide, including:
Nausea
Vomiting
Diarrhea
Constipation
Burping
Flatulence
Indigestion
Keep in mind: Tirzepatide's side effects can sometimes be more pronounced, particularly during the dose-escalation phase. Some patients may also experience signs of low blood sugar, especially if used in combination with insulin.
Semaglutide may be a better option if you have heart disease
In March 2024, semaglutide received additional FDA approval for reducing cardiovascular risk in adults with heart disease who are overweight or obese. Clinical studies show that semaglutide reduced the risk of major adverse cardiovascular eventsāsuch as heart attack, stroke, or cardiovascular deathāby 20%.
Tirzepatide is currently being studied for similar cardiovascular benefits.
Semaglutide and tirzepatide may have benefits for other health conditionsSemaglutide has demonstrated positive outcomes in certain people with heart failure, and a recent study suggests potential kidney-related benefits for those with heart disease. It is also being studied as a treatment for metabolic dysfunction-associated steatohepatitis (MASH), also known as non-alcoholic steatohepatitis, a condition caused by excess fat accumulation in the liver.
Tirzepatide has shown promise for individuals with moderate-to-severe obstructive sleep apnea and may receive approval for this use by late 2024. Additionally, it is under investigation for potential benefits in cardiovascular risk reduction, heart failure, MASH, and chronic kidney disease.
In summary:
Mechanism: Semaglutide targets only GLP-1, while tirzepatide activates both GLP-1 and GIP receptors.
Efficacy: Tirzepatide has demonstrated superior weight loss results compared to semaglutide.
Side Effects: Both drugs have similar stomach-related side effects, though tirzepatide may be more potent and have a higher incidence of certain symptoms.
Dosing: Both are administered as weekly injections, but their doses differ.
Ultimately, the choice between these therapies will depend on individual patient needs, tolerance, and response to treatment.
Someone might choose tirzepatide over semaglutide for weight loss due to its greater efficacy in achieving higher levels of weight reduction and its dual mechanism that offers additional metabolic benefits. Others choose to switch from semaglutide to tirzepatide if they hit a weight loss plateau despite changing nutrition and physical activity habits.
When it comes down to it, itās a personal choice.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Alzheimer's disease is a type of dementia characterized by memory loss, cognitive decline, and a decline in the ability to perform daily tasks (e.g., planning and organizing). It can also affect mood and personality and impair judgment and language. Research has shown that Alzheimerās results from amyloid plaques and neurofibrillary tangles in brain tissue, which affect communication between brain neurons.
The quest for effective treatments remains a high priority. Among the promising therapeutic avenues being investigated, GLP-1 (glucagon-like peptide-1) agonists, traditionally used for managing type 2 diabetes and weight, have garnered significant attention for their potential benefits in Alzheimer's disease. In this podcast, weāll discuss the potential use of GLP-1 agonists in Alzheimerās disease and how they work.
Understanding GLP-1 AgonistsGLP-1 agonists are a class of medications primarily used to enhance insulin secretion and improve glycemic control in patients with type 2 diabetes and obesity. They mimic the effects of the natural hormone GLP-1, which is involved in glucose metabolism and appetite regulation. Besides their glucose-lowering properties, GLP-1 agonists have been observed to have various effects beyond glucose control, including neuroprotective properties.
Mechanisms of Action of GLP-1 Agonists in Alzheimer's DiseaseNeuroprotection: GLP-1 agonists have been shown to exert neuroprotective effects in preclinical models of Alzheimer's disease. They may help protect neurons from damage and death, which is crucial in a disease characterized by widespread neuronal loss. The mechanisms through which GLP-1 agonists provide neuroprotection include reducing oxidative stress, inflammation, and apoptosis (cell death).
Amyloid Beta and Tau Pathology: Alzheimer's disease is marked by the accumulation of amyloid beta plaques and tau tangles in the brain. Some studies suggest that GLP-1 agonists might influence the pathology associated with Alzheimer's disease by reducing amyloid beta deposition and tau phosphorylation. While these effects have been observed in animal models, translating these findings to human patients requires further research.
Cognitive Function: Clinical trials and studies have explored the impact of GLP-1 agonists on cognitive function in Alzheimer's patients. Preliminary results are promising, with some research indicating that GLP-1 agonists may improve cognitive function and slow cognitive decline. This effect is thought to be linked to the drugsā ability to enhance neurogenesis (the formation of new neurons) and synaptic plasticity (the ability of synapses to strengthen or weaken over time).
Metabolic Regulation: Alzheimerās disease has been associated with metabolic dysfunctions, including insulin resistance and impaired glucose metabolism. GLP-1 agonists, by improving insulin sensitivity and glucose regulation. This might address some of these metabolic abnormalities, potentially offering an additional benefit in managing Alzheimerās disease.
Clinical Evidence and Future DirectionsResearch into the use of GLP-1 agonists for Alzheimerās disease is still in its infancy, and larger, well-designed clinical trials are needed to confirm their efficacy and safety in this new context.
Moreover, while GLP-1 agonists show promise, they are not without side effects, including stomach-related side effects such as nausea, diarrhea, and constipation. As such, their use in Alzheimerās disease will require careful consideration of the risk-benefit profile for individual patients.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
In the journey of weight loss, everyone eventually reaches a plateau, even when using newer GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound). This phase is where the body finds a new set point and weight. During this plateau, some individuals may experience a gradual increase in appetite or āfood noiseā, while others can maintain their current state. Other metabolic markers like blood pressure and A1c, stabilize or only fluctuate slightly.
Itās important to remember that everyone will plateau. And itās impossible to predict the specific timing, percentage of weight loss, or speed at which a person will reach their plateau when they start a GLP-1 agonist.
What do the studies say? Clinical studies show that this plateau typically occurs a little over a year (about 60 weeks) into treatment with semaglutide. However, a common myth is that if you hit a weight loss plateau while using these medications, it means they are no longer working. And this myth can lead to unnecessary frustration and discontinuation of treatment.
I like to remind patients that reaching a new set point is a common phenomenon in many health conditions. For example, a patient on blood pressure medication will not become hypotensive indefinitely, and similarly, blood glucose levels will not decrease indefinitely with diabetes medications. So it should be no surprise that you wonāt lose weight indefinitely while taking a GLP-1 agonist. This evolutionary mechanism is essential for protecting the body against extremes.
In this podcast, weāll talk about strategies to move past the weight loss plateau if you havenāt yet met your weight loss goal.
Understanding Weight Loss PlateausA weight loss plateau occurs when you stop losing weight despite maintaining your diet and exercise routine. This is a common experience for many people on a weight loss journey, regardless of whether they are using GLP-1 agonists or not. Several factors can contribute to a plateau:
Metabolic Adaptation: As you lose weight, your metabolism slows down because your body requires fewer calories to maintain a smaller body size.
Reduced Caloric Deficit: You may lose weight quickly initially, but as you progress, the caloric deficit narrows, slowing down weight loss.
Water Retention and Muscle Gain: Changes in water balance and muscle mass can temporarily affect weight measurements.
Behavioral Factors: Over time, adherence to diet and exercise routines can wane, impacting progress.
Why GLP-1 Agonists Are Still Effective During a PlateauGLP-1 agonists continue to work by regulating appetite, improving insulin sensitivity, and promoting satiety. These mechanisms support long-term weight management and metabolic health, even if weight loss temporarily stalls. Plateaus do not negate these ongoing health benefits.
Strategies to Overcome a Weight Loss PlateauReevaluate Your Caloric Intake: As you lose weight, your caloric needs decrease. Adjust your daily caloric intake to reflect your new body weight and activity level. Consider consulting a dietitian to ensure your nutrition plan is optimal.
Increase Physical Activity: Incorporate more physical activity into your routine. Adding strength training can help build muscle, which can boost metabolism. When we lose weight, we lose both muscle and fat. Physical activity is crucial during a weight loss journey because it helps preserve lean muscle mass and boosts metabolism, ensuring that the weight loss is primarily fat rather than muscle.
Monitor Macronutrient Balance: Ensure you are consuming the right balance of proteins, fats, and carbohydrates. Protein, in particular, can help preserve muscle mass and promote satiety.
Stay Hydrated: Proper hydration is essential for overall health and can aid in weight loss. Sometimes, perceived plateaus are due to water retention, which can be mitigated by drinking adequate water.
Manage Stress and Sleep: Stress and poor sleep can negatively impact weight loss. Incorporate stress-reducing activities such as mindfulness, yoga, or hobbies you enjoy, and aim for 7-9 hours of quality sleep per night.
Review Medication Adherence: Ensure you are taking your GLP-1 agonist as prescribed. Consistency is key to reaping the full benefits of the medication. Both semaglutide and tirzepatide should be taken once weekly.
Be Patient and Persistent: Understand that plateaus are a normal part of the journey. Patience and persistence are crucial. Celebrate non-scale victories, such as improved energy levels, better blood sugar and blood pressure control, and enhanced overall health.
Increase Dose: Increasing the dose of a GLP-1 agonist may be necessary for some individuals, but it isn't always the solution. Some individuals may need dosage adjustments more frequently than every four weeks for optimal results. The goal is to find the optimal dose at which you continue to lose weight gradually, experience appetite suppression, and have minimal to no side effects.
For those taking GLP-1 agonists for weight loss without making any changes to their nutrition or physical activity levels, it's important to understand that maximizing the medication's benefits and achieving sustainable results largely depend on adopting a balanced diet and regular exercise routine.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
One common misconception about GLP-1 agonists, such as semaglutide (Wegovy) and tirzepatide (Zepbound), is that once you start taking them, you can never stop. This myth can deter individuals from considering these highly effective medications for weight loss.
In this podcast, weāll debunk this myth and provide a clearer understanding of how GLP-1 agonists can be included in a comprehensive health plan.
Understanding the Role of GLP-1 AgonistsGLP-1 agonists help with weight loss and diabetes management by:
Reducing appetite and promoting feelings of fullness.
Slowing gastric emptying, leading to longer periods of satiety.
Enhancing insulin sensitivity and lowering blood glucose levels.
These effects make it easier for individuals to adhere to a healthy diet and lifestyle, leading to weight loss and improved metabolic health.
Can You Stop Taking GLP-1 Agonists?Yes, you can stop taking GLP-1 agonists, but there are important considerations:
Risk of Weight Regain: Stopping GLP-1 agonists without a plan may lead to weight regain. This is because the medication's appetite-suppressing and metabolic effects will decrease, making it harder to maintain a calorie deficit and consume smaller portions.
Lifestyle Changes: To sustain weight loss after stopping GLP-1 agonists, individuals must continue to follow healthy eating habits, engage in regular physical activity, and make other lifestyle modifications (e.g., focus on stress management, sleep, and fixing hormonal imbalances).
Gradual Transition: In some cases, a gradual reduction in dosage may be recommended to help the body adjust and minimize the risk of weight regain.
Medical Supervision: Before discontinuing GLP-1 agonists, it is crucial to consult with a healthcare provider. They can provide guidance on how to transition off the medication and implement strategies to maintain weight loss.
Successful Maintenance After Stopping GLP-1 AgonistsTo successfully maintain weight loss after stopping GLP-1 agonists, consider the following strategies:
Regular Monitoring: Keep regular appointments with your healthcare provider to monitor weight and metabolic health.
Healthy Diet: Continue following a balanced diet rich in whole foods, including fruits, vegetables, and lean proteins. Youāll also want to focus on the order in which you eat certain foods: starting with vegetables, then lean proteins and healthy fats, and finally, complex carbohydrates. This will help keep your blood sugar levels stable, avoiding spikes and crashes in energy.
Hydration: Did you know that dehydration is often confused with hunger? The general rule is to take your weight in pounds and divide the number in half. This is about how many ounces of water you should drink daily.
Physical Activity: Regular exercise can increase energy levels, enhance sleep quality, and reduce the risk of type 2 diabetes, heart disease, and cancer. It also helps alleviate chronic pain and stress, leading to improved mood and overall well-being. But most importantly, regular exercise helps prevent the loss of lean muscle mass and in turn boosts our metabolism. Engage in regular physical activity, aiming for at least 150 minutes of moderate-intensity exercise per week or 75 minutes of vigorous activity per week.
Behavioral Strategies: Use behavioral strategies to manage emotional eating and stress, such as mindfulness, cognitive-behavioral therapy (CBT), or joining a support group.
Set Realistic Goals: Set realistic and achievable goals for weight maintenance and overall health.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
GLP-1 agonists, such as semaglutide (Wegovy), are popular medications for weight loss that work by mimicking the action of the GLP-1 hormone, which helps regulate appetite and blood sugar levels. While these medications can be very effective, some individuals might experience fluctuations in their appetite over time. If you've noticed that your appetite seems to be coming back even while on a GLP-1 agonist, youāre not alone. In this podcast, weāll discuss why this might be happening and what you can do to manage it.
Why Appetite Might ReturnAdaptation Over Time
Body Adaptation: As you continue with the medication, your body might adapt to the drug's effects. This adaptation can sometimes lead to a gradual decrease in the medication's effectiveness in controlling hunger.
Tolerance Development: Similar to other medications, the body can sometimes develop a tolerance, which may reduce the appetite-suppressing effects of GLP-1 agonists.
Dietary and Lifestyle Factors
Caloric Deficit: If youāve been eating fewer calories, your body may signal hunger more strongly as it tries to maintain its energy balance.
Nutrient Imbalance: Eating a diet that's lacking in essential nutrients can lead to increased hunger and cravings.
Dehydration: Symptoms of mild dehydration, such as headache, fatigue, lightheadedness, and difficulty concentrating, can mimic those of hunger.
Youāre not getting enough sleep: Sleep is closely connected to hormonal balance, especially hormones that control hunger and fullness. When youāre sleep-deprived, leptin, which signals that you're full, drops, making you feel hungrier and more prone to overeating. Meanwhile, ghrelin, the hormone that boosts appetite, increases with lack of sleep, intensifying cravings and contributing to weight gain.
Emotional and Psychological Factors
Stress and Emotional Eating: High stress or emotional challenges can lead to changes in appetite and eating patterns, sometimes overriding the effects of appetite-regulating medications.
Hormonal Fluctuations
Hormonal Changes: Your body is pretty smart. It knows what to do to maintain itself. When you lose weight and reach a new lower weight, your body might push back. This happens because of ghrelin, the āhunger hormoneā. When you lose weight, levels of ghrelin go up, making you hungry again.
Tips to Help Stay Full LongerFocus on Protein
Include Protein-Rich Foods: Protein can help keep you full longer by promoting satiety. Incorporate lean meats, beans, lentils, tofu, and Greek yogurt into your meals.
Eat Fiber-Rich Foods
Incorporate Fiber: Foods high in fiber, such as fruits, vegetables, whole grains, and legumes, can help you feel fuller for longer periods. Fiber slows down digestion and helps maintain stable blood sugar levels. But remember to start slow. Too much fiber can cause constipation.
Stay Hydrated
Drink Water: Sometimes thirst is mistaken for hunger. Drinking plenty of water throughout the day can help manage your appetite and prevent overeating. The general rule is to take your weight in pounds and divide the number in half. This is about how many ounces of water you should drink daily.
Monitor Portion Sizes
Control Portions: Eating smaller, balanced meals more frequently can help regulate hunger and prevent overeating. Be mindful of portion sizes and try to avoid large, infrequent meals.
Mindful Eating
Practice Mindfulness: Pay attention to your hunger cues and eat slowly. Mindful eating helps you recognize when youāre actually hungry and when youāve had enough.
Regular Physical Activity
Exercise Regularly: Engaging in physical activity can help regulate your appetite and improve overall metabolism. Aim for a mix of cardiovascular, resistance, and flexibility exercises. This will help preserve lean muscle mass, which is important for maintaining a higher metabolic rate.
Manage Stress
Stress Reduction Techniques: To control emotional eating, incorporate stress-management practices into your routine, such as meditation, yoga, or deep-breathing exercises.
Consult with Your Healthcare Provider
Review Your Medication: If youāre consistently experiencing increased appetite despite following these strategies, discuss it with your healthcare provider. They might adjust your dosage or suggest an alternative treatment plan.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
In a recent study published in JAMA Ophthalmology, researchers explored a possible link between the medication semaglutide and a rare type of eye stroke called non-arteritic anterior ischemic optic neuropathy (NAION). In this podcast, weāll explain what this means and why it's important.
What is NAION?
NAION is a condition that affects the optic nerve, leading to sudden vision loss in one eye. It's considered a rare eye stroke and is not related to artery disease.
What is Semaglutide?
Semaglutide is a medication used to help manage blood sugar levels in people with type 2 diabetes and is also prescribed for weight loss. It works by increasing insulin secretion in response to meals, which helps regulate blood sugar levels. Semaglutide also helps reduce appetite and increase feelings of satiety, leading to lower calorie intake. It slows the emptying of the stomach, prolonging the feeling of fullness after eating.
The Study's Findings
The researchers discovered a link between semaglutide and NAION. However, it's important to note that this is just a link. It doesn't prove that semaglutide causes NAION. Showing a connection is only the first step, and proving causation is much more challenging.
Possible Explanations
Rapid Changes in the Body: When someone starts taking semaglutide, their body undergoes quick cardiovascular and metabolic changes. These changes could trigger NAION, rather than the medication itself being the direct cause.
Common Risk Factors: People who take semaglutide often have conditions like high blood pressure, obstructive sleep apnea, or diabetes. These conditions already put them at higher risk for NAION. Semaglutide might just be a common factor among these patients, rather than the cause of their eye issues.
Study Limitations
The authors note that since their institution specializes in eye conditions, they are more likely to encounter higher numbers of NAION cases. This may limit the generalizability of their findings to other settings.
Additionally, the study's records indicate only whether a medication was dispensed to a patient, not whether it was actually taken as prescribed. This distinction is important for accurately assessing the medication's impact.
Furthermore, due to NAION's rarity, the analysis included only a small number of cases, which can complicate the interpretation of statistical results.
What Does This All Mean?
Scientists need to conduct further studies to determine if semaglutide directly causes NAION or if other factors are at play. And they should be conducted in a larger and more diverse population.
Expert Picks:
If youād like to listen about the benefits of semaglutide, check out the following podcasts:
Long-Term Health Benefits of Semaglutide for Weight Loss
How GLP-1 Agonists Like Semaglutide Fight Inflammation
The Use of GLP-1 Agonists in Post-Heart Attack Care
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
What is Metabolism?
Metabolism refers to the biochemical processes in which our bodies convert food and drink into energy. This energy is then used to fuel bodily functions such as breathing, circulating blood, and repairing cells.
Metabolism is divided into two categories:
Catabolism: Catabolism is the set of metabolic pathways that break down molecules into smaller units to release energy. It involves the breakdown of complex molecules such as carbohydrates, fats, and proteins into simpler ones like glucose, fatty acids, and amino acids. This breakdown process releases energy, which is captured in the form of adenosine triphosphate (ATP), the primary energy carrier in cells. In simple terms, catabolism is the breakdown of molecules to obtain energy.
Anabolism: Anabolism is the set of metabolic pathways that construct molecules from smaller units. These biosynthetic processes require energy, which is often derived from ATP produced during catabolic reactions. Anabolism is responsible for the growth and repair of tissues, the storage of energy, and the production of molecules necessary for cellular functions. In simple terms, anabolism is the synthesis of compounds needed by the cells.
How Does Metabolism Maintain Weight?Our body weight is determined by the balance between the calories we consume and the calories we expend. Metabolism plays an important role in this balance:
Basal Metabolic Rate (BMR): This is the amount of energy expended while at rest. It accounts for about 60-80% of daily calorie expenditure and includes the energy required for vital functions like breathing and keeping the heart beating.
Thermic Effect of Food (TEF): This is the energy required for digestion, absorption, and removal of ingested nutrients. It accounts for about 10% of daily energy expenditure.
Physical Activity: This includes all movements, from exercise to daily activities like walking or cleaning. It can vary greatly among individuals and is the most variable component of our energy expenditure.
What Happens to Our Metabolism When We Lose Weight?When we lose weight, several changes occur in our metabolism:
Reduction in BMR:
Loss of Lean Body Mass: During weight loss, especially if itās rapid or involves severe calorie restriction, some of the weight loss can be from lean muscle mass. Since muscle tissue is more metabolically active than fat tissue, a decrease in muscle mass leads to a reduction in BMR.
Smaller Body Size: A smaller body requires fewer calories to maintain. As you lose weight, your body mass decreases, and thus the energy required to sustain basic bodily functions also decreases.
Adaptive Thermogenesis:
Metabolic Adaptation: The body responds to caloric restriction and weight loss by becoming more energy-efficient. This means that for a given level of activity, the body will burn fewer calories. This adaptive thermogenesis is believed to be a survival mechanism developed during periods of food scarcity in human history.
Decreased Energy Expenditure from Physical Activity:
Reduced Body Mass: When you weigh less, the energy cost of physical activities decreases. For instance, walking or running requires less energy if you are lighter.
Why Steady Weight Loss is Better than Rapid Weight LossSteady, gradual weight loss is generally considered more effective and sustainable than rapid weight loss for several reasons we just mentioned:
Preservation of Lean Muscle Mass: Slow weight loss helps preserve lean muscle mass, which is crucial for maintaining a higher metabolic rate.
Sustainable Habits: Gradual weight loss encourages the development of healthy, sustainable habits rather than quick fixes that are difficult to maintain.
Also, keep in mind that rapid weight loss can lead to nutrient deficiencies, as it often involves restrictive diets that may lack essential nutrients. This can cause deficiencies that may impact overall health, energy levels, immune function, and more. Itās imperative that we focus on adequate intake of lean proteins, healthy fats, and complex carbohydrates in addition to vitamins and minerals to maintain our metabolism.
Also, slow, steady weight loss is associated with a lower risk of regaining the lost weight compared to rapid weight loss.
How GLP-1 Receptor Agonists Affect MetabolismGLP-1 (glucagon-like peptide-1) receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) help with weight loss and affect metabolism. They work by:
Increasing Insulin Secretion: GLP-1 agonists increase insulin secretion in response to meals, which helps regulate blood sugar levels.
Reducing Appetite: These medications help reduce appetite and increase feelings of satiety, leading to lower calorie intake.
Slowing Gastric Emptying: GLP-1 agonists slow the emptying of the stomach, which prolongs the feeling of fullness after eating.
When we lose weight, it can have both positive and negative effects on metabolism:
Positive Effects:
Improved insulin sensitivity
Lowered risk of chronic diseases such as diabetes, heart disease, and high blood pressure
Improved insulin sensitivity allows cells to more efficiently take up glucose from the bloodstream, which is then used for energy production. This process helps maintain stable energy levels throughout the day.
When insulin sensitivity is high, excess glucose is effectively stored as glycogen in the liver and muscles. This stored glycogen can be used during periods of increased energy demand, such as exercise.
Improved insulin sensitivity also helps keep blood sugar levels in check, preventing hyperglycemia (high blood sugar), which can damage blood vessels, nerves, and organs over time.
When cells respond well to insulin, the pancreas does not need to produce as much insulin to achieve the same effect. Lower insulin levels reduce the risk of developing insulin resistance and type 2 diabetes.
Lower insulin levels can also reduce fat accumulation and promote fat breakdown. Also, the body can more efficiently break down stored fats for energy, especially during periods of fasting or exercise.
Improved insulin sensitivity helps regulate hunger and satiety hormones, such as leptin. This regulation can lead to better appetite control and reduced cravings, supporting weight management efforts.
Efficient glucose uptake and utilization prevent the energy crashes and hunger pangs that can occur with insulin resistance, leading to more stable eating patterns.
Insulin is an anabolic hormone, meaning it promotes protein synthesis and muscle tissue growth. Improved insulin sensitivity enhances this effect, helping to maintain and build muscle mass, which is metabolically active and boosts overall metabolic rate.
Insulin resistance is associated with chronic low-grade inflammation, which can impair metabolic functions. Improved insulin sensitivity helps reduce inflammation, supporting better metabolic health.
Negative Effects:
Potential loss of lean muscle mass if weight loss is too rapid (decreases our BMR)
Ways to Boost MetabolismWhile metabolism is largely determined by genetics, age, and sex, there are several ways to boost it:
Build Muscle: Engaging in strength training exercises helps build muscle mass, which can increase BMR.
Stay Active: Regular physical activity, including both aerobic and anaerobic exercises, helps burn calories and maintain a healthy weight.
Eat Protein-Rich Foods: Protein has a higher thermic effect compared to fats and carbohydrates, meaning it requires more energy to digest.
Stay Hydrated: Drinking water can temporarily boost metabolism, especially if the water is cold, as the body uses energy to heat it to body temperature.
Get Enough Sleep: Poor sleep can negatively affect metabolism and increase the risk of weight gain.
Manage Stress: Chronic stress can lead to hormonal imbalances that negatively affect metabolism and appetite.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
When embarking on a weight loss journey, it's important to be aware that losing weight can sometimes result in the loss of muscle mass along with fat. This unintended muscle loss can lead to decreased strength, slower metabolism, a less toned appearance, or extra skin.
To counteract this, it's essential to incorporate foods that support muscle maintenance and growth into your diet. Consuming adequate protein, healthy fats, and nutrient-dense carbohydrates can help preserve muscle mass, ensuring that your weight loss is both healthy and sustainable.
In this podcast, weāll discuss what foods are best to help maintain muscle mass while taking a GLP-1 agonist like semaglutide or tirzepatide.
How does weight loss affect muscle mass?
Weight loss can affect muscle mass in several ways, depending on how the weight loss is achieved:
Caloric Deficit: Weight loss typically requires a caloric deficit, meaning you consume fewer calories than your body needs to maintain its current weight. If the deficit is too large or if protein intake is insufficient, the body may start to break down muscle tissue for energy, leading to a loss of muscle mass.
Exercise: Incorporating strength training or resistance exercises during weight loss can help preserve and even build muscle mass. Conversely, focusing solely on cardio without any form of resistance training may lead to a higher proportion of muscle loss.
Protein Intake: As we mentioned, adequate protein intake is important for preserving muscle mass during weight loss. Protein provides the necessary building blocks (amino acids) for muscle repair and growth. Insufficient protein can lead to muscle catabolism, where muscle tissue is broken down.
Rate of Weight Loss: Rapid weight loss often results in a higher percentage of muscle loss compared to slower, more gradual weight loss. A slower rate of weight loss allows the body to better preserve muscle tissue while losing fat.
To minimize muscle loss during weight loss, it's important to:
Include resistance training in your exercise routine
Consume adequate protein
Avoid excessively large caloric deficits
Aim for a gradual and sustainable rate of weight loss
What foods help maintain muscle mass while losing weight on a GLP-1?
Remember that this discussion doesnāt include all foods that can help support muscle maintenance and growth but itās a good start.
Chicken breast: Itās high in quality protein (22 grams per serving) and leucine. Chicken breast is also low in calories, which can help you lose weight. Try removing the chicken skin to help lower the amount of saturated fat.
Fish (Salmon, Tuna): Fish is a great source of protein and omega-3 fatty acids, which have anti-inflammatory effects and support muscle recovery. Studies also show that omega-3 fatty acids can help reduce muscle soreness. One serving of salmon provides about 20 grams of protein while one serving of fresh tuna provides about 28 grams of protein.
Eggs: A complete protein source that contains all essential amino acids, as well as vitamins and minerals like vitamin D and leucine (amino acid), which support muscle function. Eggs are often called the āperfect proteinā. One large hard-boiled egg provides about 6 grams of protein.
Greek Yogurt: High in protein and often lower in sugar than regular yogurt, Greek yogurt also provides probiotics that support digestive health. Like eggs, Greek yogurt provides all essential amino acids.
Pro tip: Keep in mind that Greek yogurt is better than plain yogurt as it provides nearly double the amount of protein (17 grams per serving) that plain yogurt provides in the same portion size. If youāre watching carbohydrate intake, Greek yogurt has about half as much as regular yogurt. Also, plain Greek yogurt is better than flavored Greek yogurt. This is because flavored yogurt has added sugar.
Low-fat cottage cheese (2% milk fat): Another dairy product high in protein and also contains casein, a slow-digesting protein thatās beneficial for muscle maintenance during periods of fasting (such as overnight) and weight loss. There are about 30 grams of protein in one serving of low-fat cottage cheese.
Legumes (Lentils, Chickpeas): Plant-based sources of protein, fiber, and micronutrients like iron and magnesium, which support muscle function and recovery.
Nuts and Seeds: Rich in healthy fats, protein, and micronutrients like vitamin E , iron, and magnesium. Baru nuts and almonds are high in fiber and polyphenols that help your body recover from strenuous exercise. Each provides about that out 7 grams of protein per serving.
Tofu and Edamame: Plant-based sources of protein also provide phytoestrogens and minerals like calcium, which are beneficial for lean muscle growth. One serving of firm tofu provides about 11 grams of protein while cooked edamame provides about 18 grams of protein.
Quinoa: A whole grain that is also a complete protein like eggs and Greek yogurt. Quinoa provides carbohydrates for energy and protein (about 8 grams per serving) for muscle repair. It also is a good source of iron that helps provide energy and restores your musclesā glycogen stores after exercise helping to prevent muscle fatigue.
How to Incorporate These Foods
To maintain muscle mass while on GLP-1 agonists, consider these tips:
Balance Protein Intake: Aim for 0.8 to 1.2 grams of protein per kilogram of body weight per day, distributed evenly throughout meals, especially if youāre also exercising. A 200 lb person should aim for around 200 grams of protein per day.
Include Resistance Training: To stimulate muscle growth and maintenance, combine a balanced diet with regular resistance exercises (e.g., planks, push-ups, squats).
Stay Hydrated: Proper hydration supports muscle function and recovery.
Itās always important to consult with a healthcare professional or a registered dietitian to tailor dietary recommendations to individual needs and health goals.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Digestion is a complex process that involves breaking down food into nutrients that the body can absorb and use. For a healthy person, the time it takes to digest meals and snacks can vary based on the type and composition of the food consumed. Keep in mind the digestive process varies significantly between healthy individuals and those with digestive disorders. While healthy individuals typically digest meals within a predictable timeframe, digestive disorders can cause delays or speed up this process.
Keep in mind that GLP-1 agonists like semaglutide (Wegovy) and tirzepatide (Zepbound) influence digestion by slowing gastric emptying and regulating appetite, which can be beneficial for weight loss and diabetes management but may pose challenges for those with certain digestive conditions.
In this podcast, weāll discuss how digestion is impacted by digestive orders and how GLP-1 agonists like semaglutide (Wegovy) and tirzepatide (Zepbound) affect digestion.
The Digestive Process ExplainedStarting in the Mouth: The digestive process begins in the mouth when you chew food. Chewing breaks down food into smaller particles, and saliva, which contains an enzyme that starts the digestion of starches, moistens the food, making it easier to move along the gastrointestinal (GI) tract.
Moving to the Esophagus: When you swallow, food travels down the esophagus. Here, peristalsisārhythmic contractionsāautomatically propel the food forward. At the lower end of the esophagus, a circular muscle called the lower esophageal sphincter (LES) relaxes to allow food to pass into the stomach and then closes to prevent stomach acid from flowing back into the esophagus.
Stomach Function: Once food reaches the stomach, muscles in the stomach wall mix it with stomach acid and enzymes, creating digestive juices that break the food down into a liquid mixture called chyme.
The Small Intestine: In the small intestine, food mixes with digestive juices from the pancreas, liver, and gallbladder. The walls of the small intestine then absorb nutrients into the bloodstream before peristalsis moves the remaining mixture forward.
Large Intestine Function: Undigested food, fluids, and damaged cells from the GI tract's lining enter the large intestine or colon. Here, water is absorbed, transforming the waste material from liquid to stool. Peristalsis then moves the stool into the rectum, where it is stored until it is expelled during a bowel movement.
Typical Digestion Times:
Liquids: Water and other clear fluids pass through the stomach quickly, usually within 20-30 minutes.
Simple Carbohydrates: Foods like fruit, white bread, and sugary snacks are typically digested within 30-60 minutes.
Complex Carbohydrates: Whole grains, quinoa, vegetables, and legumes take longer, around 2-3 hours.
Proteins: Meat, dairy, and other high-protein foods generally take 3-4 hours to digest.
Fats: Fatty foods such as nuts, cheese, and fried foods are the slowest to digest, often taking up to 6 hours or more.
On average, the entire digestive process, from ingestion to elimination, can take about 24-72 hours in healthy individuals.
Digestion in Individuals with Digestive DisordersDigestive disorders can significantly alter the time it takes for food to move through the digestive system. Conditions such as gastroparesis, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD) can disrupt normal digestive function.
Gastroparesis: This condition, often caused by diabetes or other underlying issues, slows stomach emptying. Symptoms include nausea, vomiting, and bloating. In gastroparesis, digestion can be severely delayed, with food remaining in the stomach for prolonged periods, sometimes up to several hours longer than normal.
Irritable Bowel Syndrome (IBS): IBS can cause both accelerated and delayed digestion, depending on whether diarrhea-predominant (IBS-D) or constipation-predominant (IBS-C) symptoms are present. IBS-D can lead to faster transit times, while IBS-C can slow digestion, causing significant delays in the passage of food.
Inflammatory Bowel Disease (IBD): Conditions such as Crohn's disease and ulcerative colitis involve chronic inflammation of the gastrointestinal tract, which can disrupt normal digestion. Depending on the severity and location of inflammation, digestion can be faster or delayed.
What is the Impact of GLP-1 Agonists on Digestion?GLP-1 (glucagon-like peptide-1) agonists, such as semaglutide (Wegovy) and tirzepatide (Zepbound), are medications primarily used for managing type 2 diabetes and obesity. These drugs mimic the action of the GLP-1 hormone, which plays an important role in regulating appetite, insulin secretion, and gastric motility.
Slowed Gastric Emptying: GLP-1 agonists slow the rate at which food leaves the stomach. This effect can help increase feelings of fullness and reduce overall food intake, contributing to weight loss. In healthy individuals, this slowed gastric emptying can extend digestion times slightly but is generally well-tolerated.
Appetite Regulation: By acting on receptors in the brain, GLP-1 agonists reduce appetite and promote satiety. This leads to smaller meal sizes and reduced caloric intake, which can aid in weight management.
Blood Glucose Control: These medications enhance insulin secretion in response to meals and inhibit glucagon release, improving blood glucose control. This effect is particularly beneficial for individuals with type 2 diabetes but can also contribute to a more stable digestion process by preventing large spikes and crashes in blood sugar levels.
Digestion Times While Taking GLP-1 AgonistsLiquids:
Typical: 20-30 minutes
With GLP-1 Agonists: 30-60 minutes
GLP-1 agonists slow the passage of liquids, increasing digestion time slightly.
Simple Carbohydrates:
Typical: 30-60 minutes
With GLP-1 Agonists: 45-90 minutes
Simple carbs take longer to leave the stomach, prolonging the digestion time.
Complex Carbohydrates:
Typical: 2-3 hours
With GLP-1 Agonists: 3-4 hours
Complex carbs, which already take longer to digest, experience further delays.
Proteins:
Typical: 3-4 hours
With GLP-1 Agonists: 4-5 hours
Protein digestion is slowed down, leading to extended stomach retention.
Fats:
Typical: Up to 6 hours or more
With GLP-1 Agonists: 7-8 hours or more
Fatty foods, being the slowest to digest, see the most significant increase in digestion time.
Factors Affecting Digestion Times on GLP-1 AgonistsDosage: Higher doses of GLP-1 agonists tend to slow gastric emptying more, potentially leading to longer digestion times.
Individual Variability: Each person's digestive system responds differently to GLP-1 agonists, so the exact digestion times can vary.
Meal Composition: Mixed meals containing fats, proteins, and carbohydrates will generally take longer to digest, especially when combined with the effects of GLP-1 agonists.
Side Effects and Considerations: While GLP-1 agonists are effective in managing weight and blood glucose levels, they can also cause gastrointestinal side effects such as nausea, constipation, belching, and diarrhea, particularly during the initial stages of treatment or when the dose is increased. These side effects are typically temporary and go away on their own when your body gets used to the medication.
The use of GLP-1 agonists requires careful consideration and monitoring for individuals with digestive disorders. The slowed gastric emptying effect might exacerbate symptoms in conditions like gastroparesis. Therefore, it is important for patients with digestive disorders to consult their healthcare provider before starting GLP-1 agonist therapy.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Did you know that you don't need a gym to enjoy the benefits of resistance training? You can do it right in the comfort of your home with no gym equipment, and it's fantastic for your overall health and heart health. Regular resistance training can improve your blood pressure, blood sugar, blood lipids, and body composition. It's especially helpful for older adults and those with a higher risk of heart problems (e.g., high blood pressure or cholesterol, diabetes, excess weight, current or former smokers, or a family history of heart disease).
In this podcast, weāll discuss simple home workouts that you can do to help your overall health.
What is resistance training?
Resistance training, also known as strength training, involves exercises that improve muscular strength and endurance. This form of exercise typically uses resistance in the form of weights, resistance bands, or body weight to work specific muscle groups. By repeatedly challenging muscles, resistance training enhances their ability to generate force and sustain physical activity.
Benefits of Resistance Training Cardiovascular and Overall HealthWhile resistance training primarily targets muscle strength and endurance, it also offers substantial cardiovascular benefits. Regular resistance training can:
Improve heart health by reducing blood pressure and cholesterol levels.
Help keep your arteries flexible and improves blood vessel function while lowering inflammation levels that typically lead to atherosclerosis (clogged arteries).
Keep in mind that while you may not notice these cardiovascular effects, you may experience noticeable improvements in your sleep and mood.
Weight Loss and Muscle MassResistance training is a powerful tool for weight loss and muscle mass maintenance. But how?
Increased Metabolism: Building muscle boosts your resting metabolic rate, meaning you burn more calories even at rest.
Fat Loss: While you may not see immediate weight loss, resistance training can help you lose fat and gain lean muscle, leading to a healthier body composition.
Muscle Preservation: During weight loss, preserving muscle mass is crucial. When people lose weight, they usually lose fat along with muscle mass. Given the popularity of GLP-1 agonists like semaglutide (Wegovy) and tirzepatide (Zepbound), itās important to know that muscle wasting is a possible side effect of these medications. Resistance training ensures that most of the weight lost comes from fat, not muscle.
Keep in mind: Resistance training also promotes better body mechanics and posture, reducing the risk of injury and improving balance and coordination.
How to Get Started with Resistance TrainingGetting started with resistance training can be intimidating, especially if you already donāt exercise or have mobility limitations due to arthritis, neurological conditions like multiple sclerosis, or obesity.
You can always join a gym and meet with a personal trainer but we all know this is both costly and time-consuming. While in-person classes or training sessions might be motivating and fun, there is always the option of trying resistance training at home, on your own. You can find free exercise videos on YouTube or personal fitness blogs.
Set Clear Goals: Determine what you want to achieve, whether itās building muscle, losing or maintaining weight, or improving overall health.
Start with a Plan: Create a balanced workout plan that includes all major muscle groups (e.g., chest, shoulders, upper back, back and front of arms and legs, stomach, and lower back).
Learn Proper Technique: Proper form is important to prevent injuries. Consider working with a trainer initially or using reputable online resources.
Start Light: To master the exercises, begin with lighter weights, then gradually increase the resistance as you become more comfortable and stronger. Start with shorter, lower-intensity sessions to help your body readjust and minimize the risk of injury.
Consistency: Consistency is key. Aim for at least two resistance training sessions per week. Each session should last 15 to 20 minutes and focus on 8 to 10 different exercises.
Examples of Resistance Training ExercisesHere are some common resistance training exercises:
Air squats, wall squats, and lunges: Target the legs and glutes. Specifically the front and back thigh and buttocks. No equipment is needed.
Deadlifts or upright rows engage the upper back muscles. Both can be done using long resistance bands instead of weights.
Chest Press: This exercise works the chest, shoulders, and triceps. It can also be done without weights by doing push-ups, incline push-ups, or decline push-ups.
Planks or abdominal crunch: Improve core strength and stability. No equipment is needed.
Bicep Curls: Target the front upper arm. Again, if you donāt have weights at home, you can perform bicep curls using resistance bands.
Calf raises: These target the calf muscle, and no gym equipment is needed. They can be done using stairs or a chair.
Remember to adjust the intensity and frequency of workouts based on your progress and fitness goals to ensure a safe and effective resistance training regimen.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
Glucagon-like peptide 1 (GLP-1) is a hormone primarily known for its role in regulating blood sugar levels through its effects on insulin secretion and appetite control. However, recent research has shown another significant function of GLP-1: its ability to reduce inflammation. This opens new avenues for therapeutic interventions in various inflammatory conditions and chronic diseases.
In this podcast, weāll discuss GLP-1ās role in reducing inflammation and how it may help you.
What is GLP-1?
GLP-1 is an incretin hormone produced by intestinal L-cells in response to food intake. It enhances insulin secretion from the pancreas in a glucose-dependent manner.
Here's how glucose-dependent insulin secretion works:
Increase in Blood Glucose Levels: After you eat, carbohydrates in your food are broken down into glucose, which is absorbed into your bloodstream, raising your blood sugar levels.
Release of GLP-1: In response to the rising blood glucose levels, your intestines release a hormone called GLP-1 (Glucagon-Like Peptide 1).
Stimulation of the Pancreas: GLP-1 travels through your bloodstream to your pancreas, where it stimulates the beta cells in the pancreas to release insulin.
Insulin Release: The insulin is then released into your bloodstream. Insulin acts like a key, allowing glucose to enter your cells so it can be used for energy.
Glucose-Dependent Nature: The important part is that this whole process depends on the presence of glucose. If your blood glucose levels are not high, GLP-1 will not signal your pancreas to release insulin. This prevents your blood sugar from dropping too low, which could cause hypoglycemia (dangerously low blood sugar levels).
GLP-1 also slows gastric emptying and reduces appetite, which collectively help manage postprandial blood glucose levels. GLP-1 exerts its effects by binding to the GLP-1 receptor (GLP-1R), which is expressed in multiple tissues, including the pancreas, brain, heart, and immune cells.
The Link Between GLP-1 and Inflammation
Inflammation is a complex response to harmful stimuli such as pathogens, damaged cells, or irritants. Chronic inflammation contributes to many diseases, including cardiovascular diseases, diabetes, and neurodegenerative disorders.
How does GLP-1 reduce inflammation?
Modulation of Immune Cells: GLP-1 influences various immune cells, including macrophages, T cells, and dendritic cells. It has been observed to shift macrophages from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, reducing the secretion of pro-inflammatory cytokines like TNF-Ī±, IL-6, and IL-1Ī². This shift plays a crucial role in dampening the inflammatory response.
Inhibition of Nuclear Factor-kappa B (NF-ĪŗB) Pathway: NF-ĪŗB is a transcription factor that regulates the expression of genes involved in inflammation. Activation of GLP-1R has been shown to inhibit the NF-ĪŗB pathway, thereby reducing the transcription of pro-inflammatory genes. This inhibition helps in lowering the levels of inflammatory mediators in the body.
Reduction of Oxidative Stress: GLP-1 reduces oxidative stress by increasing the expression of antioxidant enzymes. Oxidative stress is a significant driver of inflammation, and by mitigating it, GLP-1 helps in lowering the inflammatory burden. This is particularly beneficial in conditions like atherosclerosis and diabetes, where oxidative stress is a major pathogenic factor.
Cardiovascular Protection: Chronic inflammation is a well-known risk factor for cardiovascular diseases. GLP-1 and its analogs have been shown to improve endothelial function, reduce vascular inflammation, and protect against atherosclerosis. These effects are mediated through the reduction of inflammatory cytokines and oxidative stress, as well as the improvement of lipid profiles.
Neuroprotection: Neuroinflammation is a critical component of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. GLP-1 analogs have demonstrated neuroprotective effects by reducing neuroinflammation, improving neuronal survival, and enhancing cognitive function. These benefits are attributed to the reduction in pro-inflammatory cytokines and the enhancement of neurotrophic factors.
Therapeutic Implications
The anti-inflammatory properties of GLP-1 have significant therapeutic implications. GLP-1 receptor agonists, initially developed for the treatment of type 2 diabetes, are now being explored for their potential in treating various inflammatory and chronic diseases.
Type 2 Diabetes and Metabolic Syndrome: The dual action of GLP-1 in regulating blood glucose and reducing inflammation makes it a promising therapeutic agent for managing type 2 diabetes and its complications.
Cardiovascular Diseases: Given the role of inflammation in atherosclerosis and other cardiovascular conditions, GLP-1 analogs could offer cardiovascular protection and improve outcomes in patients with heart disease.
Neurodegenerative Disorders: The neuroprotective and anti-inflammatory effects of GLP-1 analogs present a potential therapeutic strategy for slowing the progression of neurodegenerative diseases and improving cognitive function.
Inflammatory Bowel Disease (IBD): Preliminary studies suggest that GLP-1 analogs may help in reducing inflammation in IBD, offering a novel treatment approach for this chronic inflammatory condition.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
A class of medications known as GLP-1 receptor agonists has revolutionized the treatment of type 2 diabetes and obesity. These drugs mimic the action of glucagon-like peptide-1 (GLP-1), a hormone that stimulates insulin secretion and inhibits glucagon release, helping to regulate blood sugar levels and promote weight loss. In this podcast, weāll talk about the differences among some of the most well-known GLP-1 receptor agonists for type 2 diabetes.
Ozempic (Semaglutide)
Form: Injectable
Dosing Frequency: Once weekly
Uses: Primarily for type 2 diabetes (lower blood sugar and A1c); also approved for reducing the risk of major cardiovascular events like heart attack and stroke in adults with type 2 diabetes and known heart disease.
Keep in mind, Wegovy (semaglutide) is a higher-dose version thatās approved for weight loss. When you start taking Wegovy or Ozempic, youāll begin with a low dosage. Your prescriber will increase your dosage every four weeks until you reach the target amount. However, the specific dosage you inject will differ depending on the medication. The maximum dose for Ozempic is 2mg weekly, while the target dose for Wegovy is 2.4mg weekly.
Rybelsus (Semaglutide)Form: Oral tablet
Dosing Frequency: Once daily
Uses: Lower blood sugar and A1c in people with type 2 diabetes.
Rybelsus shares the same active ingredient as the injectable medications Ozempic and Wegovy. Ozempic is also approved for Type 2 diabetes, while Wegovy is approved specifically for weight loss.
Rybelsus is available in three different strengths: 3 mg, 7 mg, and 14 mg. Similar to Ozempic, the dose is slowly increased every 4 weeks.
Good to know: It's important to take Rybelsus first thing in the morning with 4 oz of water. After taking it, you should wait at least 30 minutes before eating, drinking, or taking other medications. Failing to do so may reduce its effectiveness.
Currently, Rybelsus is undergoing clinical trials to evaluate its effectiveness for weight loss. The trials involve higher doses than those approved for diabetes treatment. Results indicate that a 50 mg dose of oral semaglutide (Rybelsus) achieves weight loss comparable to Wegovy.
Trulicity (Dulaglutide)Form: Injectable
Dosing Frequency: Once weekly
Uses: Type 2 diabetes; and like Ozempic, itās also approved for reducing the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
Like Ozempic and Rybelsus, you will start at a low dose to help reduce side effects. Your healthcare provider will then gradually increase the dose, balancing the management of side effects with the benefits of blood sugar control. The maximum dose for Trulicity is 4.5mg weekly.
Victoza (Liraglutide)Form: Injectable
Dosing Frequency: Once daily
Uses: Type 2 diabetes; also approved to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
Victoza is one of three GLP-1 agonists approved for treating Type 2 diabetes in children aged 10 and older. The other options are Trulicity (dulaglutide) and Bydureon BCise (exenatide). More on this later. Ozempic, however, is only approved for use in adults.
Saxenda and Victoza are both injectable medications containing liraglutide, but they are approved for different uses. Saxenda is FDA-approved for chronic weight management in people 12 and older, while Victoza is approved for treating Type 2 diabetes in people 10 and older. Victoza also helps lower the risk of major adverse cardiovascular events in adults with diabetes and heart disease.
Both medications are injected once a day, starting with a low dose that is gradually increased over time. The target dose for Saxenda is 3 mg once daily, whereas the maximum dose for Victoza is 1.8 mg once daily.
Byetta (Exenatide)Form: Injectable
Dosing Frequency: Twice daily
Uses: Type 2 diabetes.
Additional Benefits: It has a shorter duration of action than other GLP-1 agonists, which may be preferable for some patients.
Byetta, approved in 2005, was the first GLP-1 medication of its kind for diabetes. Its active ingredient, exenatide, is a synthetic version of a substance found in Gila monster saliva.
The recommended starting dose for Byetta is 5 mcg twice daily, administered within 60 minutes before your morning and evening meals. After one month, your healthcare provider may increase the dose to 10 mcg twice daily. Starting at a lower dose helps reduce stomach-related side effects.
Bydureon BCise (Exenatide Extended-Release)Form: Injectable
Dosing Frequency: Once weekly
Uses: Type 2 diabetes.
Additional Benefits: Extended-release formulation provides a more convenient dosing schedule compared to Byetta.
Unlike Byetta, Bydureon BCise has a fixed dose of 2 mg administered once weekly, on the same day each week. It can be taken at any time of day, with or without food.
Mounjaro (Tirzepatide)Form: Injectable
Dosing Frequency: Once weekly
Uses: Type 2 diabetes.
Additional Benefits: Dual action as it targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, potentially offering enhanced efficacy in blood sugar control.
Mounjaro is not approved for weight loss; however, its active ingredient, tirzepatide, is approved for weight loss under the brand name Zepbound.
Typically, Mounjaroās starting dose is 2.5 mg once weekly for four weeks. By week 5, the dosage is often increased to 5 mg once weekly for another four weeks. Following week 9, if necessary for better blood sugar management, the dosage can be escalated to 7.5 mg weekly.
It's important not to increase Mounjaro doses by more than 2.5 mg every four weeks. The maximum recommended dosage is 15 mg once weekly.
Unlike Ozempic, Trulicity, or Victoza, Mounjaro is currently not approved for any heart-related uses. However, an ongoing clinical trial is assessing its effectiveness in reducing major adverse cardiovascular events in people with Type 2 diabetes. The study is anticipated to conclude in October 2024.
Key Differences and ConsiderationsThe right GLP-1 agonist for you will likely come down to a few key factors like age, treatment goals, and underlying health conditions. Personal preferences like dosage frequency will also come into play.
Dosing Frequency:
Once weekly: Ozempic, Trulicity, Bydureon BCise, Mounjaro.
Once daily: Rybelsus (oral), Victoza, Saxenda.
Twice daily: Byetta.
Administration Form:
Injectable: All except Rybelsus (oral).
Oral: Rybelsus.
Indications:
Type 2 Diabetes: All medications.
Cardiovascular Benefits:
Proven cardiovascular benefits: Ozempic, Trulicity, Victoza.
Pediatric Use:
Approved for children: Victoza (for children 10 years and older).
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
-
As you age, you might notice dark or brown spots (hyperpigmentation) appearing on your face, arms, or the tops of your hands. These age spots can also develop on your legs, back, and other parts of your body.
Age spots on the face (cheek, chin, nose, forehead, and upper lip) are typically caused by years of exposure to ultraviolet light from the sun (melasma). These age spots are more common in women and those who are pregnant or taking birth control pills. While experts don't know exactly why this is, it's thought that hormones play a role in melasma.
Keep in mind that age spots can also be caused by skin injury, such as a cut, burn, or acne breakout. They can also be caused by inflammation, certain medications, and medical conditions such as hypothyroidism, Addison's disease, and certain vitamin deficiencies (B12 or folate).
While you can't go back in time to apply more sunscreen and prevent age spots, there are peptide therapies that you can use to fade them.
As a refresher, peptides are short chains of amino acids. When used topically, they can penetrate the skin and signal cells to perform specific functions, such as collagen production, skin repair, and pigment regulation.
In this podcast, we'll talk about how peptide therapy works to help get rid of the appearance of age spots and what you can expect:
How Does Peptide Therapy Work for Age Spots?
Inhibition of Melanin Production:
Certain peptides can inhibit the activity of tyrosinase, an enzyme crucial for the synthesis of melanin (a dark brown pigment). These peptides help lighten dark spots and even out skin tone by reducing melanin production.
Promotion of Skin Renewal:
Peptides can stimulate skin cell turnover, promoting the shedding of pigmented cells and the generation of new, healthier skin cells. This helps in fading dark spots over time.
Anti-Inflammatory Effects:
Peptides can reduce inflammation, which often contributes to hyperpigmentation, especially in conditions like post-inflammatory hyperpigmentation (PIH).
Antioxidant Properties:
Some peptides have antioxidant properties, protecting the skin from oxidative stress and damage caused by UV radiation, which can exacerbate dark spots.
What are Some Common Peptides Used for Treating Dark Spots?
Copper Peptides:
Known for their wound healing and anti-inflammatory properties, copper peptides can help improve skin texture and reduce pigmentation.
Palmitoyl Tetrapeptide-7:
This peptide reduces inflammation and promotes the regeneration of new skin cells, helping to diminish dark spots over time.
Oligopeptide-68:
Specifically designed to reduce hyperpigmentation by inhibiting melanin production and evening out skin tone.
Decapeptide-12:
Effective in reducing pigmentation and improving overall skin brightness.
What are the Benefits of Peptide Therapy for Dark Spots?
Targeted Action:
Peptides can be formulated to specifically target pigmentation pathways, offering a more precise approach compared to general skin-lightening agents.
Minimal Side Effects:
Peptides are generally well-tolerated, with a lower risk of irritation and side effects than more aggressive treatments like chemical peels or laser therapy.
Multi-functional Benefits:
In addition to lightening dark spots, peptides often provide additional skin benefits such as improved texture, firmness, and hydration.
Application and Usage of Peptides for Age Spots
Topical Serums and Creams: Peptides are commonly found in serums and creams. These should be applied as directed, typically once or twice daily, after cleansing and before moisturizing.
Consistency is Key: Peptide therapy results can take several weeks to become noticeable. Consistent use is crucial for achieving the best results.
Sun Protection: Peptides used to treat dark spots should be paired with effective sun protection. Sunscreen helps prevent further pigmentation and supports the action of peptides. As a general rule, make sure to choose sunscreen that is broad-spectrum (protects against UVA and UVB rays), SPF 30 (or higher), and water-resistant.
If you are considering peptide therapy for dark spots, it's recommended to consult with a dermatologist to determine the most suitable peptides for your skin type and condition. Often, combining adequate sunscreen, prescription medications, peptide therapy, and certain procedures such as microdermabrasion, lasers, and chemical peels may be needed.
Thanks again for listening to The Peptide Podcast. We love having you as part of our community. If you love this podcast, please share it with your friends and family on social media, and have a happy, healthy week!
We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.
Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.
- Laat meer zien
